
    
      We designed a prospective, randomized trial to test the hypotheses that DHA supplementation
      to human milk providers will increase DHA concentration in milk and infant blood levels; and
      that infants receiving milk from DHA-supplemented providers will be receiving a more
      appropriate enteral intake to better mimic intrauterine accretion. In addition, we
      hypothesize that pro-inflammatory cytokines will be reduced in the mothers and infants
      receiving the higher DHA diet.
    
  